Protective effects of S(+) ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs

Toxicology

Volumn 234, Issue 3, 2007, Pages 185-193

  Dorandeu, Frederic ^a   Baille, Valerie ^a   Mikler, John ^b   Testylier, Guy ^a   Lallement, Guy ^a   Sawyer, Thomas ^b   Carpentier, Pierre ^a  

^a CENTRE DE RECHERCHES   (France)

^b DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

Delayed treatment of status epilepticus; S(+) ketamine; Soman

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ATROPINE; ATROPINE METHYL NITRATE; KETAMINE; KETANEST; PYRIDOSTIGMINE; SOMAN;

ABDOMINAL SWELLING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATAXIA; BRAIN DAMAGE; CONTROLLED STUDY; CONVULSION; DRUG EFFICACY; EPILEPTIC STATE; GUINEA PIG; IMMOBILIZATION; LETHALITY; LUNG EDEMA; MALE; NERVOUSNESS; NONHUMAN; PRIORITY JOURNAL; REFLEX; RESPIRATORY TRACT DISEASE; TREMOR; WEAKNESS;

ANIMALS; ATROPINE; BRAIN DAMAGE, CHRONIC; CHOLINESTERASE INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GUINEA PIGS; KETAMINE; LETHAL DOSE 50; MALE; MUSCARINIC ANTAGONISTS; PYRIDINIUM COMPOUNDS; SOMAN; STATUS EPILEPTICUS; STEREOISOMERISM;

CAVIA;

EID: 34247478108     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.02.012     Document Type: Article

References (39)

1. Ballough G., Kan R., Fath D., Tompkins C., Misuro S., and Filbert M. Neuroprotection following nerve agent-induced seizures, a comparison of combined treatment efficacies: dantrolene-diazepam vs. ketamine-diazepam. 15th Biennal Bioscience Medical Defense Review. Hunt Valley, MD (2006)
2. Björkman S., Akeson J., Nilsson F., Messeter K., and Roth B. Ketamine and midazolam decrease cerebral blood flow and consequently their own rate of transport to the brain: an application of mass balance pharmacokinetics with a changing regional blood flow. J. Pharmacokinet. Biopharm. 20 (1992) 637-652
3. Braitman D.J., and Sparenborg S. MK-801 protects against seizures induced by the cholinesterase inhibitor soman. Brain Res. Bull. 23 (1989) 145-148
4. Brandt C., Potschka H., Loscher W., and Ebert U. N-methyl-d-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 118 (2003) 727-740
5. Carpentier P., Delamanche I.S., Le-Bert M., Blanchet G., and Bouchaud C. Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. Neurotoxicology 11 (1990) 493-508
6. Carpentier P., Foquin A., Kamenka J.M., Rondouin G., Lerner-Natoli M., de Groot D.M.G., and Lallement G. Effects of thienylphencyclidine (TCP) on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neurotoxicity. Neurotoxicology 22 (2001) 13-28
7. Carpentier P., Foquin A., Rondouin G., Lerner Natoli M., de Groot D.M.G., and Lallement G. Effects of atropine sulphate on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neuropathology. Neurotoxicology 21 (2000) 521-540
8. Carpentier P., Foquin Tarricone A., Bodjarian N., Rondouin G., Lerner Natoli M., Kamenka J.M., Blanchet G., Denoyer M., and Lallement G. Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. Neurotoxicology 15 (1994) 837-851
9. Cavalheiro E.A., Santos N.F., and Priel M.R. The pilocarpine model of epilepsy in mice. Epilepsia 37 (1996) 1015-1019
10. Chen J.W., and Wasterlain C.G. Status epilepticus: pathophysiology and management in adults. Lancet Neurol. 5 (2006) 246-256
11. Dorandeu F., Carpentier P., Baubichon D., Four E., Bernabe D., Burckhart M.F., and Lallement G. Efficacy of the ketamine-atropine combination in the delayed treatment of soman-induced status epilepticus. Brain Res. 1051 (2005) 164-175
12. Dorandeu, F., Lallement, G., Carpentier, P., Filliat, P., Collombet, J.-M., Ruttimann, M., 2003. Neuroprotection et neurotoxiques organophosphorés: quelle place pour la kétamine? In: Mion, G. (Ed.), Kétamine, Arnette, Rueil-Malmaison, pp. 77-96.
13. Ebert U., Brandt C., and Loscher W. Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat. Epilepsia 43 (2002) 86-95
14. Göransson-Nyberg A., and Cassel G. Cardiopulmonary effects of HI-6 treatment in soman intoxication. J. Appl. Toxicol. 21 (2001) S79-S81
15. Kohrs R., and Durieux M.E. Ketamine: teaching an old drug new tricks. Anesth. Analg. 87 (1998) 1186-1193
16. Lallement G., Clarençon D., Brochier G., Baubichon D., Galonnier M., Blanchet G., and Mestries J.C. Efficacy of atropine/pralidoxime/diazepam or atropine/HI-6/prodiazepam in primates intoxicated by soman. Pharmacol. Biochem. Behav. 56 (1997) 325-332
17. Lallement G., Clarençon D., Galonnier M., Baubichon D., Burckhart M.F., and Peoc'h M. Acute soman poisoning in primates neither pretreated nor receiving immediate therapy: value of gacyclidine (GK-11) in delayed medical support. Arch. Toxicol. 73 (1999) 115-122
18. Lallement G., Clarençon D., Masqueliez C., Baubichon D., Galonnier M., Burckhart M.F., Peoch H., and Mestries J.C. Nerve agent poisoning in primates: antilethal, anti-epileptic and neuroprotective effects of GK-11. Arch. Toxicol. 72 (1998) 84-92
19. Lallement G., Dorandeu F., Filliat P., Carpentier P., Baille V., and Blanchet G. Medical management of organophosphate-induced seizures. J. Physiol. Paris 92 (1998) 369-373
20. Lallement G., Foquin A., Baubichon D., Burckhart M.F., Carpentier P., and Canini F. Heat stress, even extreme, does not induce penetration of pyridostigmine into the brain of guinea pigs. Neurotoxicology 19 (1998) 759-766
21. Lallement G., Foquin A., Dorandeu F., Baubichon D., Aubriot S., and Carpentier P. Subchronic administration of various pretreatments of nerve agent poisoning. I. Protection of blood and central cholinesterases, innocuousness towards blood-brain barrier permeability. Drug Chem. Toxicol. 24 (2001) 151-164
22. Lawn N.D., and Wijdicks E.F.M. Progress in clinical neurosciences: status epilepticus. A critical review of management options. Can. J. Neurol. Sci. 29 (2002) 206-215
23. Lemercier G., Carpentier P., Sentenac-Roumanou H., and Morelis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. Berl. 61 (1983) 123-129
24. Lundy P.M., Hill I., Lecavalier P., Hamilton M.G., Vair C., Davidson C., Weatherby K.L., and Berger B.J. The pharmacokinetics and pharmacodynamics of two HI-6 salts in swine and efficacy in the treatment of GF and soman poisoning. Toxicology 208 (2005) 399-409
25. Myhrer T., Andersen J.M., Nguyen N.H., and Aas P. Soman-induced convulsions in rats terminated with pharmacological agents after 45 min: neuropathology and cognitive performance. Neurotoxicology 26 (2005) 39-48
26. Okumura T., Takasu N., Ishimatsu S., Miyanoki S., Mitsuhashi A., Kumada K., Tanaka K., and Hinohara S. Report on 640 victims of the Tokyo subway sarin attack. Ann. Emerg. Med. 28 (1996) 129-135
27. Petras J.M. Neurology and neuropathology of Soman-induced brain injury: an overview. J. Exp. Anal. Behav. 61 (1994) 319-329
28. Philippens I.H., Melchers B.P., de Groot D.M., and Wolthuis O.L. Behavioral performance, brain histology, and EEG sequela after immediate combined atropine/diazepam treatment of soman-intoxicated rats. Pharmacol. Biochem. Behav. 42 (1992) 711-719
29. Price M., Armstrong S., Mumford H., and Wetherell J. Intussusceptions following soman poisoning in the guinea pig: a potential problem in medical management?. 15th Biennal Bioscience Medical Defense Review. Hunt Valley, MD (2006)
30. Riban V., Bouilleret V., Pham-Le B.T., Fritschy J.M., Marescaux C., and Depaulis A. Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience 112 (2002) 101-111
31. Sankar R., Shin D., Mazarati A.M., Liu H., Katsumori H., Lezama R., and Wasterlain C.G. Epileptogenesis after status epilepticus reflects age- and model-dependent plasticity. Ann. Neurol. 48 (2000) 580-589
32. Schmued L.C., and Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874 (2000) 123-130
33. Schuttler J., Stanski D.R., White P.F., Trevor A.J., Horai Y., Verotta D., and Sheiner L.B. Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. J. Pharmacokinet. Biopharm. 15 (1987) 241-253
34. Shih T.M. Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res. 7 (1990) 105-116
35. Shih T.M., Duniho S.M., and McDonough J.H. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol. Appl. Pharmacol. 188 (2003) 69-80
36. Shih T.M., McDonough J.H., and Koplovitz I. Anticonvulsants for soman-induced seizure activity. J. Biomed. Sci. 6 (1999) 86-96
37. Sparenborg, S., Brennecke, L.H., Jaax, N.K., Braitman, D.J., 1992. Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacology 31, 357-368 (published erratum appears in Neuropharmacology 1993 Mar;32(3):313).
38. Temkin N.R., Jarell A.D., and Anderson G.D. Antiepileptogenic agents-how close are we?. Drugs 61 (2001) 1045-1055
39. Werner C., Reeker W., Engelhard K., Lu H., and Kochs E. Ketamine racemate and S-(+)-ketamine. Cerebrovascular effects and neuroprotection following focal ischemia. Anaesthesist 46 1 (1997) S55-S60